Skip to main content

Danaher Value Stock - Dividend - Research Selection

Danaher

ISIN: US2358511028 , WKN: 866197

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company\'s Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. Its Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and flow cytometry products. The company offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians\' offices, reference laboratories, and other critical care settings. Its Dental segment provides consumables, equipment, and services to diagnose, treat, and prevent disease and ailments of the teeth, gums, and supporting bone. This segment offers implant systems, dental prosthetics, and associated treatment planning software; orthodontic bracket systems and lab products; endodontic systems and related consumables; restorative materials and instruments; infection prevention products; digital imaging systems and software; air and electric powered handpieces, and consumables; and treatment units. Its Environmental & Applied Solutions segment offers instrumentation, services, and disinfection systems to analyze, treat, and manage water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, software, services, and consumables for packaging, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Franklin DynaTech SMA Q3 2024 Commentary

2024-11-21
Global equities ended 3Q24 collectively higher as they recovered from bouts of heightened volatility, including a market selloff in early August following an interest rate hike by the BoJ.

Franklin DynaTech Fund Q3 2024 Commentary

2024-11-21
Global equities ended the third quarter collectively higher as they recovered from bouts of volatility, some of which was stoked by US recession concerns.

Tracking Akre Capital Management Portfolio - Q3 2024 Update

2024-11-20
Read here for the latest updates on Akre Capital Management's 13F portfolio, with major holdings and significant stake changes in top companies.

Danaher Corp. stock rises Wednesday, outperforms market

2024-11-20
Danaher Corp. stock rises Wednesday, outperforms market

BlackRock Event Driven Equity Fund Q3 2024 Commentary

2024-11-20
BlackRock Event Driven Equity Fund The Fund was up over the quarter with hard catalyst, soft catalyst, and credit investments all contributing to returns.

Danaher Corp. stock rises Tuesday, still underperforms market

2024-11-19
Danaher Corp. stock rises Tuesday, still underperforms market

Danaher Corporation (DHR) Highlighted Milestones in its 2024 Corporate Sustainability Report

2024-11-19
Madison Investments, an investment advisor, released its “Madison Sustainable Equity Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. All equity classes experienced good results in the third quarter. During the quarter, equity markets ended on a high note, with the S&P 500 achieving a 5.89% increase, bringing the full-year […]

Fidelity Select Health Care Portfolio Q3 2024 Fund Review

2024-11-19
For Q3 2024, the Fidelity Select Health Care Portfolio fund gained 9.48%, outperforming the MSCI sector index. Click here to read the full commentary.

Danaher Corp. stock falls Monday, underperforms market

2024-11-18
Danaher Corp. stock falls Monday, underperforms market

Danaher Corp. stock falls Friday, underperforms market

2024-11-15
Danaher Corp. stock falls Friday, underperforms market